<DOC>
	<DOCNO>NCT00495859</DOCNO>
	<brief_summary>Patients endstage liver disease characteristically malnourish associated poor outcome . Formulas enrich arginine , ω3 fatty acid , nucleotide potentially improve nutritional status . This randomized placebo-controlled double blind multicenter clinical trial longterm preoperative supplementation enrich formula evaluate evaluate effect formulas patient ' quality life , survival , posttransplant morbidity .</brief_summary>
	<brief_title>Effects Preoperative Long-Term Immunonutrition Patients Listed Liver Transplantation</brief_title>
	<detailed_description>Background . Patients end stage liver disease characteristically malnourish associated poor outcome . Formulas enrich arginine , ω-3 fatty acid , nucleotide , `` immunonutrients '' , potentially improve nutritional status . This study design evaluate clinical outcome long-term `` immunonutrition '' patient end-stage liver disease wait list liver transplantation . Methods / design . A randomized control double blind multi-center clinical trial two parallel group comprise total 142 newly register patient primary liver transplantation design assess safety efficacy long-term administration ORAL IMPACT® , `` immunonutrient '' formula , wait graft . Patients enrol day registration wait list liver transplantation . Study end day transplantation . Primary endpoint include patient ' nutritional physiological status , measure mid-arm muscle area , triceps skin fold thickness , grip strength , fatigue score , well patient ' health relate quality life . Furthermore , patient follow 12 postoperative week evaluate anabolic recovery transplantation show reduced post-transplant mechanical ventilation , hospital stay , wound healing , infectious morbidity ( pneumonia , intra-abdominal abscess , sepsis , line sepsis , wound infection , urinary tract infection ) , acute chronic rejection , mortality . Discussion . Formulas enrich arginine , ω-3 fatty acid , nucleotide prove beneficial reduce postoperative infectious complication length hospital stay among patient undergo elective gastrointestinal surgery . Possible mechanisms include downregulation inflammatory response surgery immune modulation rather sole nutritional effect .</detailed_description>
	<criteria>Men woman 18 68 year age Scheduled first liver transplantation Written inform consent Proteincalorie malnutrition : Midarm muscle area ( MAMA ) &lt; 85 % standard Patients &lt; 18 &gt; 68 year Pregnant nursing woman History hypersensitivity arginine , ω3 fatty acid , nucleotides Inability take oral nutrition Patients fulminant subacute hepatic failure require urgent transplantation Mental condition render subject incapable understand nature , scope , consequence trial Simultaneous participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Immunonutrition</keyword>
	<keyword>immune enhance diet</keyword>
	<keyword>arginine</keyword>
	<keyword>ω-3 fatty acid</keyword>
	<keyword>nucleotide</keyword>
	<keyword>liver transplantation</keyword>
	<keyword>clinical trial</keyword>
</DOC>